These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 7866474)

  • 1. Evaluating success of weight loss programs, with an application to fluoxetine weight reduction clinical trial data.
    Sayler ME; Goldstein DJ; Roback PJ; Atkinson RL
    Int J Obes Relat Metab Disord; 1994 Nov; 18(11):742-51. PubMed ID: 7866474
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of fluoxetine on body weight, body composition and visceral fat accumulation.
    Visser M; Seidell JC; Koppeschaar HP; Smits P
    Int J Obes Relat Metab Disord; 1993 May; 17(5):247-53. PubMed ID: 8389333
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An open-label pilot study of the combination therapy of metformin and fluoxetine for weight reduction.
    Dastjerdi MS; Kazemi F; Najafian A; Mohammady M; Aminorroaya A; Amini M
    Int J Obes (Lond); 2007 Apr; 31(4):713-7. PubMed ID: 16969361
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analyses of suicidality in double-blind, placebo-controlled trials of pharmacotherapy for weight reduction.
    Goldstein DJ; Rampey AH; Potvin JH; Masica DN; Beasley CM
    J Clin Psychiatry; 1993 Aug; 54(8):309-16. PubMed ID: 8253699
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effects of orlistat on weight and on serum lipids in obese patients with hypercholesterolemia: a randomized, double-blind, placebo-controlled, multicentre study.
    Muls E; Kolanowski J; Scheen A; Van Gaal L;
    Int J Obes Relat Metab Disord; 2001 Nov; 25(11):1713-21. PubMed ID: 11753595
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An assessment of the thermogenic effects of fluoxetine in obese subjects.
    Stinson JC; Murphy CM; Andrews JF; Tomkin GH
    Int J Obes Relat Metab Disord; 1992 May; 16(5):391-5. PubMed ID: 1319975
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combination of diet, exercise and intermittent treatment of cimetidine on body weight and maintenance of weight loss. A 42 months follow-up study.
    Birketvedt GS; Thom E; Bernersen B; Florholmen J
    Med Sci Monit; 2000; 6(4):699-703. PubMed ID: 11208394
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A double-blind, placebo-controlled trial of fluoxetine plus behavior modification in the treatment of obese binge-eaters and non-binge-eaters.
    Marcus MD; Wing RR; Ewing L; Kern E; McDermott M; Gooding W
    Am J Psychiatry; 1990 Jul; 147(7):876-81. PubMed ID: 2192563
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Orlistat (Ro 18-0647), a lipase inhibitor, in the treatment of human obesity: a multiple dose study.
    Drent ML; Larsson I; William-Olsson T; Quaade F; Czubayko F; von Bergmann K; Strobel W; Sjöström L; van der Veen EA
    Int J Obes Relat Metab Disord; 1995 Apr; 19(4):221-6. PubMed ID: 7627244
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pattern analysis method for assessing successful weight reduction.
    Holman SL; Goldstein DJ; Enas GG
    Int J Obes Relat Metab Disord; 1994 May; 18(5):281-5. PubMed ID: 8061720
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A randomized double-blind placebo-controlled study of the long-term efficacy and safety of diethylpropion in the treatment of obese subjects.
    Cercato C; Roizenblatt VA; Leança CC; Segal A; Lopes Filho AP; Mancini MC; Halpern A
    Int J Obes (Lond); 2009 Aug; 33(8):857-65. PubMed ID: 19564877
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fluoxetine: a randomized clinical trial in the treatment of obesity.
    Goldstein DJ; Rampey AH; Enas GG; Potvin JH; Fludzinski LA; Levine LR
    Int J Obes Relat Metab Disord; 1994 Mar; 18(3):129-35. PubMed ID: 8186809
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of sibutramine-induced weight loss on cardiovascular system in obese subjects.
    de Simone G; Romano C; De Caprio C; Contaldo F; Salanitri T; di Luzio Paparatti U; Pasanisi F
    Nutr Metab Cardiovasc Dis; 2005 Feb; 15(1):24-30. PubMed ID: 15871847
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sibutramine is safe and effective for weight loss in obese patients whose hypertension is well controlled with angiotensin-converting enzyme inhibitors.
    McMahon FG; Weinstein SP; Rowe E; Ernst KR; Johnson F; Fujioka K;
    J Hum Hypertens; 2002 Jan; 16(1):5-11. PubMed ID: 11840224
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and safety of sibutramine for weight loss in obese patients with hypertension well controlled by beta-adrenergic blocking agents: a placebo-controlled, double-blind, randomised trial.
    Sramek JJ; Leibowitz MT; Weinstein SP; Rowe ED; Mendel CM; Levy B; McMahon FG; Mullican WS; Toth PD; Cutler NR
    J Hum Hypertens; 2002 Jan; 16(1):13-9. PubMed ID: 11840225
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cetilistat (ATL-962), a novel lipase inhibitor: a 12-week randomized, placebo-controlled study of weight reduction in obese patients.
    Kopelman P; Bryson A; Hickling R; Rissanen A; Rossner S; Toubro S; Valensi P
    Int J Obes (Lond); 2007 Mar; 31(3):494-9. PubMed ID: 16953261
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of fluoxetine, a selective serotonin-uptake inhibitor, in the treatment of obesity: a dose-response study (with a commentary by Michael Weintraub).
    Levine LR; Enas GG; Thompson WL; Byyny RL; Dauer AD; Kirby RW; Kreindler TG; Levy B; Lucas CP; McIlwain HH
    Int J Obes; 1989; 13(5):635-45. PubMed ID: 2583918
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exercise vs dietary change to bring about weight loss.
    Lasslo-Meeks M
    J Am Diet Assoc; 1997 Jun; 97(6):583. PubMed ID: 9183315
    [No Abstract]   [Full Text] [Related]  

  • 19. Long-term maintenance of weight loss with sibutramine in a GP setting following a specialist guided very-low-calorie diet: a double-blind, placebo-controlled, parallel group study.
    Mathus-Vliegen EM;
    Eur J Clin Nutr; 2005 Aug; 59 Suppl 1():S31-8; discussion S39. PubMed ID: 16052193
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dietary supplementation with long chain omega-3 polyunsaturated fatty acids and weight loss in obese adults.
    Munro IA; Garg ML
    Obes Res Clin Pract; 2013; 7(3):e173-81. PubMed ID: 23697585
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.